Due to recent state and federal action, the Department of Public Health (DPH) and the Bureau of Substance Addiction Services (BSAS) expects widespread disruptions in the availability of kratom products, including both natural and synthetic products. These products can act like potent opioids. Providers should anticipate a potential increase in the number of patients presenting with kratom-related withdrawal and requests for kratom-related use disorder treatment in the coming